Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion
Patient characteristics by treatment group.
IVB combined with MLP Group 1 ()
IVB only Group 2 ()
Baseline BCVA ()
Baseline CST (m)
Number of IVB during 12 months of follow-up
Number of MLP during 12 months of follow-up
Duration between onset of BRVO and first IVB (days)
Duration between first IVB and second IVB (months)
BCVA = best corrected visual acuity; CST = central subfield thickness; MLP = macular laser photocoagulation; IVB = intravitreal bevacizumab; VA = logarithm of the minimal angle of resolution visual acuity; NS = not significant; NA = not available; Mann-Whitney test; bchi-square test.